PRAX (Praxis Medicines) Net earnings per share (EPS TTM)

Symbol and logo of brand praxismedicines.com (PRAX)

Praxis Precision Medicines (PRAX) will only gain pricing power following regulatory approval, as the company currently relies on investor capital. Fundamental TTM earnings per share help track this trend, where the value of -12.86 corresponds to the current metric. While the brand carries scientific weight in CNS treatment, it faces intense pressure from industry behemoths and the risks of clinical trial failures.

PRAX praxismedicines.com Net earnings per share for the last four quarters (07/04/2022 - 11/16/2026)

Comprehensive metric breakdowns and analytics for Praxis Corp (PRAX)

- share price and expert price forecast:
General company analysis:Praxis Corp (PRAX)
Mass-produced product of Praxis Medicines

For Praxis Precision Medicines (PRAX), which develops targeted ion channel therapies for rare epilepsies, trailing twelve months (TTM) net earnings per share serve as an indicator of intellectual property capitalization efficiency. By analyzing the trend of rolling annual earnings per share, an investor assesses the actual return per share of capital, enabling the timely identification of financial trend reversals and the protection of assets from impairment.

Main competitors

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|AVXL (anavex.com) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last twelve months Prothena Biosciences (PRTA)|Net earnings per share for the last four quarters Alector|Net earnings per share (EPS TTM) ANNX (annexonbio.com)|Earnings per share for the trailing year OMER|NGNE: Net earnings per share for the last 12 months|ACIU (AC Immune Corp) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters cassavasciences.com (SAVA)|Assertio Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Coya Therapeutics COYA|VTGN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharmaceuticals|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|CLNN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen Inc PEPG|Net earnings per share for the last four quarters jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ANVS (annovisbio.com)|Grace Tx (GRCE) - Earnings per share for the last twelve months|Firefly Neuroscience (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year